Natco Pharma appoints Amit Parekh as new Executive Vice President - Finance and Accounts

Ruchika Sharma

Natco Pharma appoints Amit Parekh as new Executive Vice President - Finance and Accounts

Written By : Ruchika Sharma Published On 2025-12-02T13:40:17+05:30 | Updated On 2 Dec 2025 1:40 PM IST

Telangana: Natco Pharma has announced the appointment of Amit Parekh as its new Executive Vice President - Finance and Accounts of the Company.

This strategic move is a part of the company’s structured succession planning.

As per the recent BSE filing, subject to necessary approvals; Amit Parekh will succeed S.V.V.N. Appa Rao, Chief Financial Officer of the Company at the Board meeting to be held in the month of February 2026.

Read also: Natco Pharma to buy significant stakes in South African Drugmaker Adcock Ingram

Amit Parekh has more than 20 years of experience, with a proven track record of managing financial and business affairs for top Indian companies in diverse industries, including healthcare, pharma, mining and engineering, telecommunications, and chemicals. Few of his core competencies are CXO Level engagements, Investment & M&A (including in & out licencing deals in Pharma space), Cost leadership Projects, Financial Analysis and Reporting, Financial Management & Accounting (IFRS, IND AS, US GAAP) and Risk Assessment & Compliance, etc., he was previously associated with Dr. Reddy’s Laboratories Limited as Head of Finance -API and Pharmaceutical Services (PSAI) and Head of Digital Transformation in Finance.

Read also: Natco Pharma acquires 35.75% stake in Adcock Ingram for USD 226 million

Natco Pharma Limited is a public limited company, listed on the Bombay Stock Exchange and the National Stock Exchange of India, with a market capitalisation of c. US$ 2 billion. Established in 1981, NATCO Pharma has evolved into a diversified pharmaceutical manufacturer, with a primary focus on research and development, manufacturing, and global marketing of both finished dosage formulations and active pharmaceutical ingredients. NATCO Pharma operates across various geographies (in over 50 countries), including emerging and developed markets, with a particular focus on delivering quality medicines in oncology, cardiology, neurology, and other high-value therapeutic categories.

natco pharmanatco pharma newsappointmentAmit Parekh

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751